Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
106.15
-0.23 (-0.22%)
At close: Apr 24, 2025, 4:00 PM
102.52
-3.63 (-3.42%)
After-hours: Apr 24, 2025, 6:03 PM EDT

Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $132.33 billion as of April 24, 2025. Its market cap has increased by 53.02% in one year.

Market Cap
132.33B
Enterprise Value
149.42B
1-Year Change
53.02%
Ranking
Category
Stock Price
$106.15

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $132.33B, an increase of 13,498.83%. That is a compound annual growth rate of 20.44%.

History

DateMarket Cap% Change
Apr 23, 2025132.48B15.08%
Dec 31, 2024115.12B14.04%
Dec 29, 2023100.94B-6.25%
Dec 30, 2022107.68B18.22%
Dec 31, 202191.08B24.72%
Dec 31, 202073.03B-11.17%
Dec 31, 201982.21B1.60%
Dec 31, 201880.92B-13.53%
Dec 29, 201793.58B-0.81%
Dec 30, 201694.34B-35.31%
Dec 31, 2015145.83B2.55%
Dec 31, 2014142.21B23.49%
Dec 31, 2013115.15B106.93%
Dec 31, 201255.65B81.01%
Dec 30, 201130.74B4.49%
Dec 31, 201029.42B-24.44%
Dec 31, 200938.94B-16.37%
Dec 31, 200846.56B8.73%
Dec 31, 200742.82B43.43%
Dec 29, 200629.86B24.03%
Dec 30, 200524.07B58.92%
Dec 31, 200415.15B28.36%
Dec 31, 200311.80B76.49%
Dec 31, 20026.69B6.07%
Dec 31, 20016.30B61.59%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 772.11B
UnitedHealth Group 386.34B
Johnson & Johnson 372.82B
AbbVie 319.11B
Novo Nordisk 276.96B
Abbott Laboratories 224.40B
AstraZeneca 215.41B
Novartis AG 208.99B
Market Cap Rankings